Northern Trust Corp Kala Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $95,955 - $419,006	-319,852 Reduced 79.51%	82,452 $25,000
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $28,421 - $85,729	-46,592 Reduced 10.38%	402,304 $556,000
Q4 2021 Feb 08, 2022	SELL	$1.16 - $2.74 $69,264 - $163,608	-59,711 Reduced 11.74%	448,896 $543,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $48,519 - $100,558	18,519 Added 3.78%	508,607 $1.33 Million
Q2 2021 Aug 13, 2021	BUY	$5.06 - $8.15 $205,547 - $331,069	40,622 Added 9.04%	490,088 $2.6 Million
Q1 2021 May 12, 2021	SELL	$6.24 - $9.58 $199,767 - $306,694	-32,014 Reduced 6.65%	449,466 $3.03 Million
Q4 2020 Feb 11, 2021	SELL	$6.28 - $8.79 $44,600 - $62,426	-7,102 Reduced 1.45%	481,480 $3.26 Million
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $372,885 - $552,366	-49,718 Reduced 9.24%	488,582 $3.67 Million
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $2.12 Million - $3.51 Million	254,707 Added 89.81%	538,300 $5.66 Million
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $184,701 - $423,897	48,225 Added 20.49%	283,593 $2.49 Million
Q4 2019 Feb 14, 2020	SELL	$3.36 - $4.81 $25,398 - $36,358	-7,559 Reduced 3.11%	235,368 $868,000
Q3 2019 Nov 13, 2019	BUY	$3.57 - $6.58 $159,461 - $293,908	44,667 Added 22.53%	242,927 $924,000
Q2 2019 Aug 13, 2019	BUY	$4.93 - $8.8 $45,272 - $80,810	9,183 Added 4.86%	198,260 $1.27 Million
Q1 2019 May 13, 2019	BUY	$5.19 - $8.97 $425 - $735	82 Added 0.04%	189,077 $1.56 Million
Q4 2018 Feb 12, 2019	BUY	$4.29 - $9.94 $248,948 - $576,818	58,030 Added 44.31%	188,995 $925,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $148,528 - $215,942	15,569 Added 13.49%	130,965 $1.29 Million
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $234,186 - $307,963	-17,608 Reduced 13.24%	115,396 $1.59 Million
Q1 2018 May 09, 2018	BUY	$12.26 - $18.98 $735,600 - $1.14 Million	60,000 Added 82.19%	133,004 $2.11 Million
Q4 2017 Feb 14, 2018	SELL	$13.68 - $23.17 $122,586 - $207,626	-8,961 Reduced 10.93%	73,004 $1.35 Million
Q3 2017 Nov 13, 2017	BUY	$19.86 - $26.53 $1.63 Million - $2.17 Million	81,965	81,965 $1.87 Million

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$5
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account